We are live on
!
Find out more
JDR
Jay D. Rosenbaum Portfolio holdings
AUM
$6.69M
1-Year Est. Return
4.68%
This Fund
S&P 500
This Quarter
Est. Return
+9.3%
1 Year Est. Return
+4.68%
3 Year Est. Return
+12.92%
5 Year Est. Return
+74.65%
10 Year Est. Return
+173.05%
AUM
$56.5M
AUM Growth
+$4M
(+7.6%)
Cap. Flow
-$443K
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
42.5%
Holding
49
New
–
Increased
14
Reduced
32
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$320K |
| 2 |
Procter & Gamble
PG
|
+$161K |
| 3 |
Microsoft
MSFT
|
+$154K |
| 4 |
Johnson & Johnson
JNJ
|
+$137K |
| 5 |
3M
MMM
|
+$90.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$421K |
| 2 |
CVS Health
CVS
|
+$274K |
| 3 |
ExxonMobil
XOM
|
+$208K |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$192K |
| 5 |
SLB Ltd
SLB
|
+$121K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Healthcare | 20.91% |
| 3 | Financials | 12.8% |
| 4 | Consumer Staples | 10.47% |
| 5 | Industrials | 9.14% |
Similar funds
RVM
KIM
ACM
HVM
BGC
QC
CU
PWA
Jay D. Rosenbaum's Q4 2019 Portfolio in Review
As of Q4 2019, Jay D. Rosenbaum held 49 positions worth $56.5M, up 7.6% from $52.5M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2%. Jay D. Rosenbaum opened no new positions and exited 1, leaving the 49-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Jay D. Rosenbaum added most to Amgen in Q4 2019, an estimated $320K increase.
- Jay D. Rosenbaum's biggest Q4 2019 reduction was CVS Health, cutting an estimated $274K.
- Jay D. Rosenbaum fully exited Abbott in Q4 2019, selling an estimated $421K.
- Jay D. Rosenbaum's ten largest holdings make up 43% of its $56.5M portfolio in Q4 2019.
- Jay D. Rosenbaum opened 0 new positions and closed 1 in Q4 2019.
- Jay D. Rosenbaum's portfolio value rose 7.6% quarter-over-quarter to $56.5M.
Based on Jay D. Rosenbaum's 13F filing for Q4 2019, filed 27 Jan 2020.